Structure Based Drug Design

Add to your list(s) Download to your calendar using vCal

• Jon Read, Judit Debreczeni and Andrew Doré
• Thursday 11 December 2014, 16:30-18:00
• Building 310 on the Cambridge Science Park.

If you have a question about this talk, please contact Claus Bendtsen.

The first AstraZeneca hosted seminar at our Darwin building on the Cambridge Science Park. The seminar will consist of three presentations:

1) A dual fragment/biochemical screening approach to targeting InhA, a Tuberculosis target by Jon Read from AstraZeneca

2) Structure-based design of potent and selective inhibitors of the metabolic kinase PFKFB3 by Judit Debreczeni from AstraZeneca

3) Crystal Structure of a Class C GPCR – metabotropic glutamate receptor 5 (mGluR5) by Andrew Doré from Heptares

Abstracts & registration @ https://eventbrite.co.uk/event/14503848401

This talk is part of the Science@Darwin series.

This talk is included in these lists:

• Building 310 on the Cambridge Science Park
• Cambridge Infectious Diseases
• Science@Darwin

Note that ex-directory lists are not shown.